Biomarkers: Troponin testing--risk stratification to stratified medicine.

Published

Journal Article

Among patients with diabetes mellitus and ischaemic heart disease, high-sensitivity testing effectively identified 39.3% of patients with elevated troponin levels who were at high 5-year risk of cardiovascular death, myocardial infarction, or stroke. Compared with optimal medical therapy, revascularization did not reduce ischaemic events among patients with elevated troponin levels.

Full Text

Duke Authors

Cited Authors

  • Newby, LK; Ohman, EM

Published Date

  • November 2015

Published In

Volume / Issue

  • 12 / 11

Start / End Page

  • 625 - 626

PubMed ID

  • 26440981

Pubmed Central ID

  • 26440981

Electronic International Standard Serial Number (EISSN)

  • 1759-5010

Digital Object Identifier (DOI)

  • 10.1038/nrcardio.2015.157

Language

  • eng

Conference Location

  • England